SEC Filings

Filing date	Description	Form	View
May 07, 2019	Quarterly report which provides a continuing view of a company's financial position	10-Q	0001564590-19-016603.pdf 0001564590-19-016603.rtf 0001564590-19-016603.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Apr 24, 2019	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001193125-19-117139.pdf 0001193125-19-117139.rtf 0001193125-19-117139.xls View HTML
Apr 24, 2019	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-19-117144.pdf 0001193125-19-117144.rtf 0001193125-19-117144.xls View HTML
Apr 04, 2019	EFFECT	EFFECT	9999999995-19-000605.pdf 9999999995-19-000605.rtf View HTML
Apr 02, 2019	CORRESP	CORRESP	0001193125-19-095709.pdf 0001193125-19-095709.rtf 0001193125-19-095709.xls View HTML
Mar 22, 2019	UPLOAD	UPLOAD	0000000000-19-005518.pdf 0000000000-19-005518.rtf View HTML
Mar 21, 2019	CT ORDER	CT ORDER	9999999997-19-001683.pdf 9999999997-19-001683.rtf View HTML
Mar 15, 2019	Simplified registration form	S-3	0001193125-19-076767.pdf 0001193125-19-076767.rtf 0001193125-19-076767.xls View HTML
Mar 15, 2019	Securities offered to employees pursuant to employee benefit plans	S-8	0001193125-19-076784.pdf 0001193125-19-076784.rtf 0001193125-19-076784.xls View HTML
Mar 15, 2019	Statement of changes in beneficial ownership of securities	4	0001209191-19-019712.pdf 0001209191-19-019712.rtf View HTML

Data provided by Kaleidoscope.

About Cara Therapeutics